Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Murray

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Laboratory Medicine|October 9, 2025
An atypical finding on serum immunofixation: a case reportAmeerah Davids, David F Keren, Annalise E Zemlin, et al.
Journal of Immunological Methods|December 15, 2020
Monitoring Ravulizumab effect on complement assaysMaria A V Willrich, Paula M Ladwig, Mark A Martinez, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|February 26, 2024
Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround timePaula M Ladwig, Ann L Rivard, Alex Barbeln, et al.
American Journal of Hematology|April 26, 2017
The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinicPaolo Milani, David L Murray, David R Barnidge, et al.
Mayo Clinic Proceedings|December 11, 2021
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple SclerosisRuba S Saadeh, Sandra C Bryant, Andrew McKeon, et al.
American Journal of Clinical Pathology|September 27, 2012
Laboratory persistence and clinical progression of small monoclonal abnormalitiesDavid L Murray, Justin L Seningen, Angela Dispenzieri, et al.
Clinical Chemistry|June 8, 2019
Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass SpectrometryLusia Sepiashvili, Mindy C Kohlhagen, Melissa R Snyder, et al.
The Journal of Applied Laboratory Medicine|May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined SignificanceKrasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
Transfusion|January 27, 2021
In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levelsJustin E Juskewitch, Josiah D Murray, Andrew P Norgan, et al.
Clinical Chemistry and Laboratory Medicine|February 19, 2018
CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexesKari M Gurtner, Eslam Shosha, Sandra C Bryant, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Laboratory Medicine|October 9, 2025
An atypical finding on serum immunofixation: a case reportAmeerah Davids, David F Keren, Annalise E Zemlin, et al.
Journal of Immunological Methods|December 15, 2020
Monitoring Ravulizumab effect on complement assaysMaria A V Willrich, Paula M Ladwig, Mark A Martinez, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|February 26, 2024
Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround timePaula M Ladwig, Ann L Rivard, Alex Barbeln, et al.
American Journal of Hematology|April 26, 2017
The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinicPaolo Milani, David L Murray, David R Barnidge, et al.
Mayo Clinic Proceedings|December 11, 2021
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple SclerosisRuba S Saadeh, Sandra C Bryant, Andrew McKeon, et al.
American Journal of Clinical Pathology|September 27, 2012
Laboratory persistence and clinical progression of small monoclonal abnormalitiesDavid L Murray, Justin L Seningen, Angela Dispenzieri, et al.
Clinical Chemistry|June 8, 2019
Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass SpectrometryLusia Sepiashvili, Mindy C Kohlhagen, Melissa R Snyder, et al.
The Journal of Applied Laboratory Medicine|May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined SignificanceKrasimira Rozenova, Maria Willrich, Melissa Snyder, et al.
Transfusion|January 27, 2021
In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levelsJustin E Juskewitch, Josiah D Murray, Andrew P Norgan, et al.
Clinical Chemistry and Laboratory Medicine|February 19, 2018
CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexesKari M Gurtner, Eslam Shosha, Sandra C Bryant, et al.
Pageof 13